MedPass International
15
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
26.7%
4 terminated/withdrawn out of 15 trials
60.0%
-26.5% vs industry average
0%
0 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
A Study in Patients with a Descending TAA or PAU Treated with the E-nya Thoracic Stent Graft System
Role: collaborator
HighLife™ Transcatheter Mitral Valve Replacement System Study
Role: collaborator
A Study in Patients With Complicated Type B Aortic Dissection Treated With the E-nya Thoracic Stent Graft
Role: collaborator
Randomized Clinical Trial on Transanal Irrigation
Role: collaborator
NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases
Role: collaborator
A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)
Role: collaborator
A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve
Role: collaborator
Evaluation of the Safety and Performance of ESTYME® MATRIX Round and Anatomical Breast Implants - EMMIE Study
Role: collaborator
Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation
Role: collaborator
Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer
Role: collaborator
CaveoVasc System - a New Femoral Vascular Access and Closure Device
Role: collaborator
Study Assessing Safety and Performance of OrtoWell Distractor in Patients Undergoing Spinal Surgery
Role: collaborator
CaveoVasc Thrombolysis Protection System, Access Protection Study
Role: collaborator
PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon
Role: collaborator
GlucoClearTM System ICU Study
Role: collaborator
All 15 trials loaded